Tanya Baker
Family · Fowlerville, MINPI 1851958078
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Boehringer Ingelheim at 32.0% of the total. Reporting peaked in 2022 at $1,197 and has fallen 97.3% since, to $32 in 2024.
Across 150 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$803
- GSK$272
- AbbVie$268
- Johnson & Johnson$238
- Novartis$203
- Actelion Pharmaceuticals US, Inc.$94
- plus $636 from 25 others
What the payments were for
- Food & beverage$2,514100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 43 | $803 |
| GSK | 20 | $272 |
| AbbVie | 11 | $268 |
| Johnson & Johnson | 16 | $238 |
| Novartis | 23 | $203 |
| Actelion Pharmaceuticals US, Inc. | 4 | $94 |
| E.r. Squibb & Sons, L.L.C. | 2 | $59 |
| Novo Nordisk | 3 | $54 |
| Electromed, Inc. | 3 | $49 |
| Pulmonx Corporation | 1 | $44 |
| Philips North America LLC | 2 | $41 |
| Biogen | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Harmony Biosciences LLC | 1 | $26 |
| Boston Scientific | 1 | $25 |
| Tactile Systems Technology Inc | 1 | $21 |
| Advanced Respiratory, Inc | 1 | $20 |
| AstraZeneca | 1 | $19 |
| Pfizer | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Covis Pharma GmbH | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
How this compares
$2,514 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 16 | $287 |
| Atorvastatin Calcium | 19 | $226 |
| Lisinopril | 19 | $220 |
| Metoprolol Succinate | 14 | $166 |
| Levothyroxine Sodium | 14 | $162 |
| Omeprazole | 13 | $160 |
| Amlodipine Besylate | 17 | $158 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 15 | $141 |
| Escitalopram Oxalate | 15 | $121 |
Paid to pharmacies, not to this prescriber.
Other family in Fowlerville
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.